A Phase 1, Open-label, Randomized, Three-period, Crossover Study to Evaluate Pharmacokinetic Interaction Between Bexagliflozin Tablets and Metformin, Glimepiride, or Sitagliptin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Bexagliflozin (Primary) ; Glimepiride; Metformin; Sitagliptin
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Theracos
- 11 Apr 2017 Status changed from active, no longer recruiting to completed.
- 09 Mar 2017 Planned End Date changed from 1 Feb 2018 to 1 Mar 2017.
- 09 Mar 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Mar 2017.